Sarmiento, Evelyn .

HRN: 26-95-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CEFUROXIME 750MG (VIAL)
11/20/2025
11/26/2025
IV
1.5g
Q8
Placenta Previa
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines